Navigation Links
Tibotec Presents Interim Findings for TMC435, an Investigational Genotype 1 Hepatitis C Treatment, at the AASLD Liver Meeting 2008
Date:11/1/2008

Nearly 90 percent of patients achieve undetectable viral load in Phase IIa trial within 28 days of combined treatment with standard of care

SAN FRANCISCO, Nov. 1 /PRNewswire/ -- New clinical data show antiviral activity of TMC435, an investigational protease inhibitor (PI) being developed by Tibotec BVBA for the treatment of chronic hepatitis C virus (HCV) infection. Tibotec will present findings from three TMC435 studies, including a late-breaker poster on the proof-of-principle phase IIa trial, OPERA-1 (TMC435-C201), at the American Association for the Study of Liver Disease's (AASLD) Liver Meeting 2008 in San Francisco.

The current standard of care treatment for HCV infection, pegylated interferon (Peg-IFN) combined with ribavirin (RBV), is effective in 30 to 50 percent of patients infected with chronic genotype 1 HCV infection, the most common type in the United States.(1) The development of new therapies and strategies for treating HCV, particularly the introduction of direct antivirals, may offer patients a new option with shorter treatment duration.(2,3)

TMC435 Phase IIa Study Results

In interim findings from the first 28 days of treatment for the first cohort of fifty (50) treatment naive HCV+, genotype 1, patients (once daily dose of 25 mg or 75 mg TMC435 versus placebo), both doses showed dose-dependent antiviral activity. TMC435 was administered in combination with PegIFNalpha-2a/RBV (triple therapy) for 28 days or as monotherapy for seven days and, thereafter, in combination with PegIFNalpha-2a/RBV (triple therapy) for three weeks. There were neither serious adverse events, nor grade 3 or 4 adverse events, related to TMC435 or any safety-related treatment discontinuations during this 28 day treatment period.

The most common adverse events associated with TMC435 were nausea, diarrhea, and headache. There were no clinically relevant changes in laboratory parameters, ECGs, or vital signs. Steady-state plasma trough
'/>"/>

SOURCE Tibotec BVBA
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. AHF Criticizes Tibotec Over Steep Price for Newest AIDS Drug, Etravirine
2. Tibotec Conducts Two Pivotal Phase III Clinical Trials Studying TMC278 in Treatment-Naive Adults with HIV
3. Ninety-Six Week Data on Tibotec Investigational NNRTI, TMC278, Presented at AIDS 2008
4. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
5. EntreMed Presents Data for Phase 2 Study of MKC-1 in Metastatic Breast Cancer
6. Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers
7. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
8. CEL-SCI Presents Data for CEL-1000 as a Vaccine Adjuvant with Recombinant Hepatitis B Virus Protein
9. Ardea Biosciences, Inc. Presents Results of Phase 1 Studies of RDEA806, a Novel NNRTI for HIV, at 47th ICAAC
10. Targanta Presents First Data Demonstrating In Vitro Activity and In Vivo Efficacy of Prodrugs in Osteomyelitis Models
11. Wyeth Presents Phase 3 Fracture Data for Bazedoxifene, an Investigational Therapy for Osteoporosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... August 28, 2015 The global ... USD 49.12 billion by 2020, growing at a CAGR ... new report by Grand View Research, Inc. Monitoring services ... 49.7% from 2014 to 2020.      (Logo: ... along with rising incidences of chronic diseases such as ...
(Date:8/27/2015)... 27, 2015 ieCrowd™ today announced the ... development of the company,s supplemental oxygen delivery device, ... being developed by ieCrowd,s subsidiary Smart Oxygen Solutions ... demand for oxygen based on level of activity.  ... for the Smart Oxygen device would require a ...
(Date:8/27/2015)... , Aug. 27, 2015   Proxsys ... Provider (IOPP™) is expanding its population health ... medication-focused transition of care program for hospitals ... Management," provides hospitals with technology systems and ... measures that have been mandated by Center ...
Breaking Medicine Technology:mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 2mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 3mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 4mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 5Smart Oxygen Solutions' Supplemental Oxygen Delivery Device Achieves FDA Regulatory Pathway Milestone 2Smart Oxygen Solutions' Supplemental Oxygen Delivery Device Achieves FDA Regulatory Pathway Milestone 3Smart Oxygen Solutions' Supplemental Oxygen Delivery Device Achieves FDA Regulatory Pathway Milestone 4Rx Care Management by Proxsys Rx - Transition of Care Technology Helps Prevent Hospital Medication Errors 2
... Lilly and Company (NYSE: LLY ) has ... for Working Mothers by Working Mother magazine ... http://www.newscom.com/cgi-bin/prnh/20031219/LLYLOGO) (Logo: http://photos.prnewswire.com/prnh/20031219/LLYLOGO) Celebrating its ... 100 Best Companies initiative selects the nation,s top companies ...
... Wolters Kluwer Health , a leading provider of information ... medicine, nursing, allied health and pharmacy, has announced an ... (JBI), a recognized global leader in evidence-based healthcare resources ... of an expansion of the nursing, allied health, and ...
Cached Medicine Technology:Lilly Celebrates 16th Consecutive Year as One of 100 Best Companies for Working Mothers 2Wolters Kluwer Health and the Joanna Briggs Institute Enter Exclusive Relationship to Deliver Evidence-Based Clinical Resources 2Wolters Kluwer Health and the Joanna Briggs Institute Enter Exclusive Relationship to Deliver Evidence-Based Clinical Resources 3Wolters Kluwer Health and the Joanna Briggs Institute Enter Exclusive Relationship to Deliver Evidence-Based Clinical Resources 4
(Date:8/28/2015)... (PRWEB) , ... August 28, 2015 , ... On October 3, 2015, BethAnn Telford of ... North Rim of the Grand Canyon with a shared mission: to beat brain cancer. ... canyon floor, across the canyon, then up to the South Rim over 21.1 miles and ...
(Date:8/27/2015)... ... August 27, 2015 , ... Keck Graduate Institute (KGI), ... received their White Coats at a formal ceremony recognizing them as members of the ... profession on Saturday, August 22. Symbolizing dedication to clinical service and patient care, the ...
(Date:8/27/2015)... ... August 27, 2015 , ... Workflow in labs has ... (qPCR) in the last decade. New features such as multiplexing, microfluidics, and ... flipside, where do lab managers, technicians, and researchers find handy metrics to compare ...
(Date:8/27/2015)... ... August 27, 2015 , ... Allegheny ... of just 20 adult-only medical centers in the United States to receive international ... and lungs. The Extracorporeal Life Support Organization (ELSO) , an international consortium ...
(Date:8/27/2015)... (PRWEB) , ... August 27, 2015 , ... The Naderi ... now be offering Kybella, a cutting-edge, noninvasive procedure to improve submental fat. The ... Kybella provides permanent results without surgery. Dr. Kulak is the only Board Certified ...
Breaking Medicine News(10 mins):Health News:Women Athletes Cross the Grand Canyon to Raise Funds for Brain Cancer Research – October 3rd 2Health News:KGI School of Pharmacy’s 2nd Annual White Coat Ceremony a Success 2Health News:KGI School of Pharmacy’s 2nd Annual White Coat Ceremony a Success 3Health News:KGI School of Pharmacy’s 2nd Annual White Coat Ceremony a Success 4Health News:Douglas Scientific® Webinar Outlines Comparisons of Varied qPCR Instruments 2Health News:Douglas Scientific® Webinar Outlines Comparisons of Varied qPCR Instruments 3Health News:International Organization Honors Allegheny General Hospital's Advanced Lifesaving Program for Cardiac and Respiratory Failure 2Health News:International Organization Honors Allegheny General Hospital's Advanced Lifesaving Program for Cardiac and Respiratory Failure 3Health News:International Organization Honors Allegheny General Hospital's Advanced Lifesaving Program for Cardiac and Respiratory Failure 4Health News:Noninvasive Double Chin Elimination Now Available in Herndon and Chevy Chase 2Health News:Noninvasive Double Chin Elimination Now Available in Herndon and Chevy Chase 3
... holds press conferenceEPHRATA, Pa., April 29 Did ... diagnosed with breast cancer in Pennsylvania who are uninsured or ... - are not aware of the program or how it ... Breast Cancer Coalition (PBCC), in partnership with Senator Vince Hughes, ...
... Up Its ActNEW YORK, April 29 Today, Senator ... by introducing the Safe Baby Products Act, which directs ... contaminants in personal care products marketed to or used ... study by the Campaign for Safe Cosmetics, which revealed ...
... as the lead organizational and strategic planning consultant. Led by General ... of the new healthcare delivery organization. , ... (PRWEB) April 29, 2009 ... care hospital. The hospital will be part of a health village ...
... -- Aesthetic Medical Educators Training (AMET) ... on Aesthetic Procedures over the past five years. ... physicians, nurses, physician assistants and dentists, all of ... practice.These medical professionals have been trained on a ...
... CITY, April 29 Grupo Aeroportuario del Sureste, S.A.B. ... the first privatized airport group in Mexico and operator ... Mexico, announced today that on April 26, 2009 the Mexican ... ("Swine Flu") in Mexico. On April 28, 2009 the World ...
... Controls Limit Vaccine SuppliesDALLAS, April 29 Fears of ... new vaccines, as well as meeting public demand for ... National Center for Policy Analysis. "We are facing ... six vaccines for common childhood illnesses," said NCPA Senior ...
Cached Medicine News:Health News:Free Treatment for Breast Cancer Available in Pennsylvania 2Health News:New Federal Legislation Targets Toxic Chemicals in Baby Bath Products 2Health News:Aesthetic Medical Educators Training Successfully Trains Over 2,000 Medical Professionals on Aesthetic Procedures 2Health News:Swine Flu Outbreak Illustrates Problems in Vaccine Development 2
... Top Rotation provides uncommon bi-directional flexibility, ... Hercules 6700B eliminates any conflicts between ... while providing ample leg room for ... procedures. Removable back and leg sections ...
... The schaerer axis 800 ... specially designed for those ... C-arm access. The stability, ... and the offset positioned ...
... operating table for any application. The ... unlimited C-arm access. High stability guarantees ... and cardiovascular procedures. An extension device ... can easily be attached for orthopedic ...
... The anatomy of the human body set ... new arcus-family. Thanks to the special concept of ... in all positions ergonomically adapts to the patient ... available when the C-arm is being utilised. The ...
Medicine Products: